According to an email viewed by The Business of Beauty, the company will be on hiatus while it establishes a sustainable path to return as a new company.
The company reported a long-awaited lift in net sales in its third quarter results, with increases from skincare leading the way, but clouds persist over its China recovery.
Going public is usually a pivotal moment in a company’s history, cementing its heavyweight status and setting it up for expansion. In L’Occitane’s case, delisting might be a bigger conduit for growth.
Once thought of as long-term disruptors who would change the way we shop forever, multi-brand online retailers that sell cosmetics, skincare, fragrance and more are facing multiple headwinds.
Deciem’s other skincare brand, NIOD, also sells serums with names straight out of a lab, but with more complex formulations and higher-end packaging. A decade into the science-backed skincare craze, the company believes its consumers are ready to move upmarket.
Gen-Z aren’t into all-or-nothing health practices, or the hallmarks of wellness that have become cornerstones. What’s left is something far more subversive.